ALX Oncology Inc.

0.86
-0.10 (-10.36%)
At close: Mar 13, 2025, 3:59 PM
0.86
0.00%
After-hours: Mar 13, 2025, 05:25 PM EDT

ALX Oncology Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -0.65 -3.98 -3.71 -10.38 -75.09 -56.88 -47.96
PEG Ratio 0.02 -0.17 -0.08 -0.13 -0.64 3.58 n/a
PS Ratio n/a n/a n/a n/a 2.91K 228.23 318.60
PB Ratio 0.77 3.37 -1.41 -4.29 -28.98 -3.97K 71.93
P/FCF Ratio -0.71 -4.86 -5.06 -11.86 -89.63 -74.96 -47.57
P/OCF Ratio -0.71 -4.91 -5.14 -12.72 -89.7 -76.82 -49.93
OCF/S Ratio n/a n/a n/a n/a -32.39 -2.97 -6.38
Debt / Equity Ratio 0.00 0.09 -0.03 -0.00 n/a -19.64 n/a
Quick Ratio 7.26 5.24 10.19 24.00 69.99 1.97 5.45
Current Ratio 7.26 5.24 9.57 24.00 69.99 1.97 5.45
Asset Turnover n/a n/a n/a n/a 0.00 0.45 0.19
Interest Coverage -82.4 -108.8 n/a -6.43K -53.84 -913.48 n/a
Return on Equity (ROE) -1.19 -0.85 0.38 0.41 0.39 69.72 -1.5
Return on Assets (ROA) -0.91 -0.66 -0.4 -0.22 -0.1 -1.8 -1.23
Return on Capital (ROIC) -1.1 -0.82 -0.46 -0.23 -0.1 -3.37 -1.47
Dividend Yield n/a n/a n/a n/a 0.00 n/a n/a
Payout Ratio n/a n/a n/a n/a -0.00 n/a n/a
Gross Profit Margin n/a n/a n/a n/a 9.05% 9.09% 9.05%
Net Profit Margin n/a n/a n/a n/a -3.87K% -401.23% -664.3%
Pretax Profit Margin n/a n/a n/a n/a -3.85K% -400.52% -662.12%
Operating Profit Margin n/a n/a n/a n/a -3.69K% -399.98% -662.02%
FCF Margin n/a n/a n/a n/a -3.24K% -304.46% -669.71%
EBITDA Margin n/a n/a n/a n/a -3.68K% -391.14% -641.27%